Leptin signalling, obesity and prostate cancer: molecular and clinical perspective on the old dilemma

Alshaker, Heba, Sacco, Keith, Alfraidi, Albandri, Muhammad, Aun, Winkler, Mathias and Pchejetski, Dmitri (2015) Leptin signalling, obesity and prostate cancer: molecular and clinical perspective on the old dilemma. Oncotarget, 6 (34). pp. 35556-35563. ISSN 1949-2553

[thumbnail of prost obes review]
PDF (prost obes review) - Published Version
Download (787kB) | Preview


The prevalence of global obesity is increasing. Obesity is associated with general cancer-related morbidity and mortality and is a known risk factor for development of specific cancers. A recent large systematic review of 24 studies based on meta-analysis of 11,149 patients with prostate cancer showed a significant correlation between obesity and the risk of advanced prostate cancer. Further, a sustained reduction in BMI correlates with a decreased risk of developing aggressive disease. On the other hand, the correlation between consuming different products and prostate cancer occurrence/risk is limited. Here, we review the role of adipose tissue from an endocrine perspective and outline the effect of adipokines on cancer metabolism, with particular focus on leptin. Leptin exerts its physiological and pathological effects through modification of intracellular signalling, most notably activating the Janus kinase (JAK) 2/signal transducer and activator of transcription (STAT) 3 pathway and recently shown sphingolipid pathway. Both high levels of leptin in circulation and leptin receptor mutation are associated with prostate cancer risk in human patients; however, the in vivo mechanistic evidence is less conclusive. Given the complexity of metabolic cancer pathways, it is possible that leptin may have varying effects on prostate cancer at different stages of its development, a point that may be addressed by further epidemiological studies.

Item Type: Article
Uncontrolled Keywords: obesity,bmi,prostate cancer,mortality,progression,adipokine,leptin,therapy,sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups: Faculty of Medicine and Health Sciences > Research Centres > Metabolic Health
Depositing User: Pure Connector
Date Deposited: 09 Dec 2015 10:00
Last Modified: 06 Jun 2024 14:53
URI: https://ueaeprints.uea.ac.uk/id/eprint/55737
DOI: 10.18632/oncotarget.5574


Downloads per month over past year

Actions (login required)

View Item View Item